NASDAQ:LGND
Ligand Pharmaceuticals Incorporated Stock News
$73.90
+1.58 (+2.18%)
At Close: May 03, 2024
Ligand (LGND) Q4 Earnings Surpass Estimates, Stock Surges
08:36am, Wednesday, 28'th Feb 2024
Ligand Pharmaceuticals (LGND) reports encouraging fourth-quarter results as earnings and sales beat estimates. Management reiterates the 2024 financial outlook.
Why Ligand Pharmaceuticals (LGND) Dipped More Than Broader Market Today
07:01pm, Tuesday, 20'th Feb 2024
Ligand Pharmaceuticals (LGND) reachead $72.37 at the closing of the latest trading day, reflecting a -1.75% change compared to its last close.
Here's Why Ligand Pharmaceuticals (LGND) Fell More Than Broader Market
07:01pm, Monday, 12'th Feb 2024
In the latest trading session, Ligand Pharmaceuticals (LGND) closed at $75.64, marking a -0.32% move from the previous day.
Ligand Pharmaceuticals (LGND) Advances While Market Declines: Some Information for Investors
07:01pm, Monday, 05'th Feb 2024
In the closing of the recent trading day, Ligand Pharmaceuticals (LGND) stood at $74.72, denoting a +0.24% change from the preceding trading day.
Ligand Pharmaceuticals (LGND) Exceeds Market Returns: Some Facts to Consider
07:06pm, Monday, 22'nd Jan 2024
Ligand Pharmaceuticals (LGND) closed the most recent trading day at $73.39, moving +1.2% from the previous trading session.
Ligand Pharmaceuticals (LGND) Suffers a Larger Drop Than the General Market: Key Insights
07:33pm, Thursday, 11'th Jan 2024
Ligand Pharmaceuticals (LGND) closed at $72.19 in the latest trading session, marking a -1.84% move from the prior day.
Ligand (LGND) Up 9% on FDA Nod for Molluscum Infection Gel
02:17pm, Monday, 08'th Jan 2024
Following the FDA approval, Ligand's (LGND) Zelsuvmi is the first at-home treatment option available for molluscum contagiosum.
Ligand Pharmaceuticals (LGND) Exceeds Market Returns: Some Facts to Consider
07:33pm, Friday, 05'th Jan 2024
In the closing of the recent trading day, Ligand Pharmaceuticals (LGND) stood at $70.83, denoting a +0.67% change from the preceding trading day.
Ligand Pharma's at-home skin treatment gets FDA approval
05:21pm, Friday, 05'th Jan 2024
Ligand Pharmaceuticals' topical treatment for a viral skin infection has received approval from the U.S. health regulator, the company said on Friday, marking the first-ever at-home approved treatment
Ligand (LGND) Posts Long-Term Outlook, Updates Portfolio Progress
01:32pm, Wednesday, 13'th Dec 2023
Ligand (LGND) aims to generate annual core sales of around $290 million by 2028. It expects revenues from royalties to witness a CAGR of 16% over the next five years.
12 Companies That Had IPOs in 1992: Best and Worst Performers
08:48am, Saturday, 09'th Dec 2023
In 1992, about 412 companies had an initial public offering (IPO) in the United States.
Here's Why Ligand Pharmaceuticals (LGND) is a Strong Value Stock
11:20am, Friday, 01'st Dec 2023
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
How Much Upside is Left in Ligand (LGND)? Wall Street Analysts Think 90.66%
11:17am, Wednesday, 22'nd Nov 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 90.7% in Ligand (LGND). While the effectiveness of this highly sought-after metric is questionable, the positiv
5 Biotech Stocks Likely to Thrive as Industry Prospects Look Bright
09:46am, Wednesday, 22'nd Nov 2023
New drug approvals and pipeline progress are likely to help maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position GILD, CRSP, ACAD,
Ligand Pharmaceuticals: A Complicated Tale
01:22pm, Wednesday, 15'th Nov 2023
Ligand Pharmaceuticals Incorporated is a biopharma company focused on developing technologies for pharmaceutical companies. The company has a wide assortment of assets it draws royalty income from and
